Cerenis Therapeutics Hldg S.A. Actions au Porteur EO -,05

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

59.78%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.16 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.806 G0 Units
PRICE DETERMINATION TIME07/20/2026 / 09:57:19 PM
DAILY VOLUME (UNITS)4,327
DAILY HIGH / LOW1.881.804
PREV. DAY'S PRICE1.86 (07/17)
CHANGE DAY BEFORE
-0.05
-2.90 %
52 WEEK HIGH / LOW5.0917 (10/28)1.1582 (07/18)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.12-0.13-0.16-0.46-0.29
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
5.325.5631.32--
PRICE - SALES RATIO
8.158.8132.56--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A14QR9
ISIN
FR0012616852
SYMBOL
609
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
CERENIS THER.HLDG EO -,05
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.75 %
-26.04 %
-50.82 %
-48.54 %
59.78 %
55.57 %
106.18 %
-44.94 %
HIGH1.892.533.804.015.095.095.094.01
LOW1.811.811.811.811.160.860.861.81

Dividende

pro Aktie
CERENIS THER.HLDG EO -,05 does not deliver dividend information

Company profile

ABIONYX Pharma SA engages in the discovery and development of novel therapies for patients without existing or effective treatments. It develops biologics and HDL-derived vectors that target the immune and inflammatory dysregulation underlying sepsis, and other severe diseases. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Balma, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.